FI105681B - Menetelmä terapeuttisesti käyttökelpoisen isopropyyli-(2-metoksietyyli)-4-(2-kloori-3-syaanifenyyli)-1,4-dihydro- 2,6-dimetyylipyridiini-3,5-dikarboksylaatin valmistamiseksi sekä menetelmän välituote - Google Patents

Menetelmä terapeuttisesti käyttökelpoisen isopropyyli-(2-metoksietyyli)-4-(2-kloori-3-syaanifenyyli)-1,4-dihydro- 2,6-dimetyylipyridiini-3,5-dikarboksylaatin valmistamiseksi sekä menetelmän välituote Download PDF

Info

Publication number
FI105681B
FI105681B FI945777A FI945777A FI105681B FI 105681 B FI105681 B FI 105681B FI 945777 A FI945777 A FI 945777A FI 945777 A FI945777 A FI 945777A FI 105681 B FI105681 B FI 105681B
Authority
FI
Finland
Prior art keywords
formula
chloro
compound
preparation
methoxyethyl
Prior art date
Application number
FI945777A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI945777A0 (fi
FI945777A (fi
Inventor
Bodo Junge
Teunis Schuurman
Zhan Gao
Bernard Schmidt
Jonge Maarten De
Heinrich Meier
Wolfgang Hartwig
Rudolfy Schohe-Loop
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4342194A external-priority patent/DE4342194A1/de
Priority claimed from DE19944424677 external-priority patent/DE4424677A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI945777A0 publication Critical patent/FI945777A0/fi
Publication of FI945777A publication Critical patent/FI945777A/fi
Application granted granted Critical
Publication of FI105681B publication Critical patent/FI105681B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal Substances (AREA)
FI945777A 1993-12-10 1994-12-08 Menetelmä terapeuttisesti käyttökelpoisen isopropyyli-(2-metoksietyyli)-4-(2-kloori-3-syaanifenyyli)-1,4-dihydro- 2,6-dimetyylipyridiini-3,5-dikarboksylaatin valmistamiseksi sekä menetelmän välituote FI105681B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4342194 1993-12-10
DE4342194A DE4342194A1 (de) 1993-12-10 1993-12-10 Halogen-phenyl-substituierte 1,4-Dihydropyridine
DE4424677 1994-07-13
DE19944424677 DE4424677A1 (de) 1994-07-13 1994-07-13 Isopropyl-(2-methoxyethyl)-4-(2-chlor-3-cyano-phenyl)-1,4-dihydro-2,6-dimethyl-pyridin-3,5-dicarboxylat

Publications (3)

Publication Number Publication Date
FI945777A0 FI945777A0 (fi) 1994-12-08
FI945777A FI945777A (fi) 1995-06-11
FI105681B true FI105681B (fi) 2000-09-29

Family

ID=25931956

Family Applications (1)

Application Number Title Priority Date Filing Date
FI945777A FI105681B (fi) 1993-12-10 1994-12-08 Menetelmä terapeuttisesti käyttökelpoisen isopropyyli-(2-metoksietyyli)-4-(2-kloori-3-syaanifenyyli)-1,4-dihydro- 2,6-dimetyylipyridiini-3,5-dikarboksylaatin valmistamiseksi sekä menetelmän välituote

Country Status (35)

Country Link
US (1) US5665740A (cs)
EP (1) EP0657430B1 (cs)
JP (1) JP3751041B2 (cs)
KR (1) KR100332325B1 (cs)
CN (2) CN1056606C (cs)
AT (1) ATE180774T1 (cs)
AU (1) AU686976B2 (cs)
BG (1) BG62487B1 (cs)
CA (1) CA2137525C (cs)
CO (1) CO4290426A1 (cs)
CU (1) CU22713A3 (cs)
CZ (1) CZ286065B6 (cs)
DE (1) DE59408350D1 (cs)
DK (1) DK0657430T3 (cs)
DZ (1) DZ1831A1 (cs)
EE (1) EE03192B1 (cs)
ES (1) ES2132308T3 (cs)
FI (1) FI105681B (cs)
GR (1) GR3030436T3 (cs)
HR (1) HRP940967B1 (cs)
HU (1) HU215593B (cs)
IL (1) IL111922A (cs)
LV (1) LV11321B (cs)
MA (1) MA23392A1 (cs)
MY (1) MY111976A (cs)
NO (1) NO302362B1 (cs)
NZ (1) NZ270087A (cs)
PL (1) PL179973B1 (cs)
RO (1) RO115800B1 (cs)
SA (1) SA95160078B1 (cs)
SK (1) SK282399B6 (cs)
SV (1) SV1994000072A (cs)
TN (1) TNSN94127A1 (cs)
TW (1) TW412529B (cs)
YU (1) YU48920B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1952824A1 (en) * 2003-11-21 2008-08-06 Memory Pharmaceuticals Corporation Compositions and methods of treatment using L-type calcium channel blockers and cholinesterase inhibitors
WO2008058234A2 (en) * 2006-11-08 2008-05-15 Memory Pharmaceuticals Corporation Pharmaceutical formulations for 1,4-dihyrdropyridine compounds having improved solubility
WO2019104041A1 (en) * 2017-11-21 2019-05-31 Michael Ohlmeyer Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963188A1 (de) * 1969-12-17 1971-06-24 Bayer Ag Neue Cyanphenyl-1,4-dihydropyridinderivate
DE2117572C3 (de) * 1971-04-10 1980-03-20 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US3932646A (en) * 1971-04-10 1976-01-13 Farbenfabriken Bayer Ag Pharmaceutical compositions containing unsymmetrical esters of 1,4-dihydropyridine 3,5-dicarboxylate
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3239273A1 (de) * 1982-10-23 1984-04-26 Bayer Ag, 5090 Leverkusen Tetrahydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US5137889A (en) * 1983-12-02 1992-08-11 Otsuka Pharmaceutical Co., Ltd. Dihydropyridine derivatives and process for preparing the same
DE3718398A1 (de) * 1987-06-02 1988-12-22 Troponwerke Gmbh & Co Kg Neue kombinationspraeparate mit antidepressiver wirkung
US5114946A (en) * 1987-06-12 1992-05-19 American Cyanamid Company Transdermal delivery of pharmaceuticals
DE3806277A1 (de) * 1988-02-27 1989-09-07 Troponwerke Gmbh & Co Kg Verwendung von 1,4-dihydropyridin-derivaten
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung
FR2671349B1 (fr) * 1991-01-09 1993-04-23 Lafon Labor Nouveaux derives de 1,4-dihydropyridine, leur procede de preparation et composition therapeutique les contenant.
DE4125271A1 (de) * 1991-07-31 1993-02-11 Bayer Ag Neue n-alkylierte 1,4-dihydropyridindicarbonsaeureester

Also Published As

Publication number Publication date
TW412529B (en) 2000-11-21
IL111922A0 (en) 1995-03-15
DZ1831A1 (fr) 2002-02-17
SA95160078B1 (ar) 2006-09-25
RO115800B1 (ro) 2000-06-30
YU48920B (sh) 2002-11-15
LV11321B (en) 1996-12-20
BG99249A (en) 1995-09-29
FI945777A0 (fi) 1994-12-08
NO944787L (no) 1995-06-12
SV1994000072A (es) 1995-08-09
NO944787D0 (no) 1994-12-09
JPH07242632A (ja) 1995-09-19
KR950017958A (ko) 1995-07-22
CZ286065B6 (cs) 2000-01-12
TNSN94127A1 (en) 1995-09-21
FI945777A (fi) 1995-06-11
CN1124258C (zh) 2003-10-15
DE59408350D1 (de) 1999-07-08
NZ270087A (en) 1996-08-27
HU215593B (hu) 1999-01-28
GR3030436T3 (en) 1999-09-30
KR100332325B1 (ko) 2002-09-04
YU71794A (sh) 1996-10-18
PL179973B1 (pl) 2000-11-30
HRP940967B1 (en) 1999-12-31
CU22713A3 (es) 1996-07-05
US5665740A (en) 1997-09-09
HU9403551D0 (en) 1995-02-28
IL111922A (en) 1999-05-09
LV11321A (lv) 1996-06-20
NO302362B1 (no) 1998-02-23
HUT70937A (en) 1995-11-28
CA2137525A1 (en) 1995-06-11
CN1244525A (zh) 2000-02-16
ES2132308T3 (es) 1999-08-16
HRP940967A2 (en) 1997-08-31
SK282399B6 (sk) 2002-01-07
CZ309394A3 (en) 1995-11-15
SK151694A3 (en) 1995-07-11
CO4290426A1 (es) 1996-04-17
MA23392A1 (fr) 1995-07-01
JP3751041B2 (ja) 2006-03-01
EP0657430B1 (de) 1999-06-02
EP0657430A1 (de) 1995-06-14
MY111976A (en) 2001-03-31
AU8030694A (en) 1995-06-15
CA2137525C (en) 2005-07-12
PL306157A1 (en) 1995-06-12
CN1109874A (zh) 1995-10-11
AU686976B2 (en) 1998-02-12
CN1056606C (zh) 2000-09-20
BG62487B1 (bg) 1999-12-30
EE03192B1 (et) 1999-06-15
ATE180774T1 (de) 1999-06-15
DK0657430T3 (da) 1999-11-15

Similar Documents

Publication Publication Date Title
FI105681B (fi) Menetelmä terapeuttisesti käyttökelpoisen isopropyyli-(2-metoksietyyli)-4-(2-kloori-3-syaanifenyyli)-1,4-dihydro- 2,6-dimetyylipyridiini-3,5-dikarboksylaatin valmistamiseksi sekä menetelmän välituote
CA1070314A (en) 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ester, several processes for its preparation and its use as a peripheral vasodilator
JP2007091750A (ja) フエニル−置換１，４−ジヒドロピリジン類の製造法
US20060025444A1 (en) Fexofenadine base polymorphic forms
CN1059442C (zh) 1,2－桥连的1,4－二氢吡啶类化合物作为药物的用途
US4742068A (en) Dihydropyridine compounds having 1,4,4-trisubstitution useful as antihypertensive agents
AU710863B2 (en) 2-chloro-3-cyano-benzaldehyde
CZ239496A3 (en) Substituted 4h-pyrans, process of their preparation, their use and pharmaceutical composition containing thereof
SK120793A3 (en) 4-heterocyclylsubstituted dihydropyridines
JPH07215965A (ja) インドールスルホンアミド−置換ジヒドロピリジン類
CH638210A5 (fr) Ester derive de l'acide quinolopyranne-4-one-2-carboxylique, procede de sa preparation et utilisation de cet ester comme compose actif dans un medicament antiallergique pour le traitement de l'asthme.
DE4424677A1 (de) Isopropyl-(2-methoxyethyl)-4-(2-chlor-3-cyano-phenyl)-1,4-dihydro-2,6-dimethyl-pyridin-3,5-dicarboxylat
DE4342194A1 (de) Halogen-phenyl-substituierte 1,4-Dihydropyridine

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

Free format text: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

PC Transfer of assignment of patent

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

Free format text: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

MM Patent lapsed